Europe: supporting the full pharma supply chain

The pharmaceutical market of western Europe is forecasted to grow from EUR254bn in 2020 to EUR299bn by 2025, with a compound annual growth rate (CAGR) of 3.4%. There are significant investments planned in the healthcare systems of Europe to better battle future pandemics. At the same time a plethora of multinational pharmaceutical companies will keep investing in Western Europe thanks to the strong regulatory environment and ability to afford high-value medicines.